Evidence map›Paper›PMID 38301653›Full record

ArticleImmunity2024

An atlas of cells in the human tonsil.

Ramon Massoni-Badosa, Sergio Aguilar-Fernández, Juan C Nieto, Paula Soler-Vila, Marc Elosua-Bayes, Domenica Marchese, Marta Kulis, Amaia Vilas-Zornoza, Marco Matteo Bühler, Sonal Rashmi and 39 more

Open access · hybridAbstract read
In one paragraph

Article in Immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
30.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CD9Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 8 countries.

Ramon Massoni-BadosaCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain. Electronic address: ram4025@med.cornell.edu.
Sergio Aguilar-FernándezCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Juan C NietoCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Paula Soler-VilaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Marc Elosua-BayesCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Domenica MarcheseCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Marta KulisInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Amaia Vilas-ZornozaHemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.
Marco Matteo BühlerInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain.
Sonal RashmiCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Clara AlsinetCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Ginevra CaratùCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Catia MoutinhoCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Sara RuizCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Patricia LordenCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Giulia LunazziCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Dolors ColomerInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain; Departament de Fonaments Clínics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.
Gerard FrigolaHematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain.
Will BlevinsCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain.
Lucia Romero-RiveroInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Víctor Jiménez-MartínezInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Anna VidalInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Judith Mateos-JaimezInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Alba Maiques-DiazInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Sara OvejeroDepartment of Biological Hematology, CHU Montpellier, Montpellier, France; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.
Jérôme MoreauxDepartment of Biological Hematology, CHU Montpellier, Montpellier, France; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France; Department of Clinical Hematology, CHU Montpellier, Montpellier, France.
Sara PalominoTranslational Bioinformatics Unit (TransBio), Navarrabiomed, Navarra Health Department (CHN), Public University of Navarra (UPNA), Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
David Gomez-CabreroTranslational Bioinformatics Unit (TransBio), Navarrabiomed, Navarra Health Department (CHN), Public University of Navarra (UPNA), Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Bioscience Program, Biological and Environmental Sciences and Engineering Division (BESE), King Abdullah University of Science and Technology KAUST, Thuwal, Saudi Arabia.
Xabier AgirreHemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain.
Marc A WenigerInstitute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Hamish W KingEpigenetics and Development Division, Walter and Eliza Hall Institute, Parkville, Australia.
Lucy C GarnerTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Federico MariniInstitute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Francisco Javier Cervera-PazDepartment of Otorhinolaryngology, University of Navarra, Pamplona, Spain.
Peter M BaptistaDepartment of Otorhinolaryngology, University of Navarra, Pamplona, Spain.
Isabel VilasecaOtorhinolaryngology Head-Neck Surgery Department, Hospital Clínic, IDIBAPS Universitat de Barcelona, Barcelona, Spain.
Cecilia RosalesInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Silvia Ruiz-GaspàInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Benjamin TalksBiosciences Institute, Newcastle University, Newcastle Upon Tyne, UK; Department of Otolaryngology, Freeman Hospital, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Keval SidhpuraBiosciences Institute, Newcastle University, Newcastle Upon Tyne, UK.
Anna Pascual-ReguantDepartment of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Immune Dynamics, Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin, Germany.
Anja E HauserDepartment of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Immune Dynamics, Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin, Germany.
Muzlifah HaniffaBiosciences Institute, Newcastle University, Newcastle Upon Tyne, UK; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Felipe ProsperHemato-Oncology Program, Center for Applied Medical Research (CIMA), University of Navarra, IDISNA, Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Departamento de Hematología, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Ralf KüppersInstitute of Cell Biology (Cancer Research), Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Ivo Glynne GutCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Elias CampoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Spain; Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain; Departament de Fonaments Clínics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.
José Ignacio Martin-SuberoInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Departament de Fonaments Clínics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Electronic address: imartins@recerca.clinic.cat.
Holger HeynCentro Nacional de Análisis Genómico (CNAG), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain. Electronic address: holger.heyn@cnag.eu.
Centro Nacional de Análisis Genómico · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital Clínic de Barcelona · ESCentre National de la Recherche Scientifique · FRCentro de Investigación Biomédica en Red de Cáncer · ESGerman Rheumatism Research Centre · DENavarrabiomed · ESUniversidad de Navarra · ESUniversitat Pompeu Fabra · ESUniversity of Duisburg-Essen · DEClinica Universidad de Navarra · ESCornell University · USInstitució Catalana de Recerca i Estudis Avançats · ESJohannes Gutenberg University Mainz · DENewcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBUniversity Hospital of Zurich · CHUniversity of Oxford · GBWalter and Eliza Hall Institute of Medical Research · AUWellcome Sanger Institute · GB

Funding

European Research Council 810287Wellcome TrustWellcome Trust 223092/Z/21/Z
6 · The paper itself

Abstract

Palatine tonsils are secondary lymphoid organs (SLOs) representing the first line of immunological defense against inhaled or ingested pathogens. We generated an atlas of the human tonsil composed of >556,000 cells profiled across five different data modalities, including single-cell transcriptome, epigenome, proteome, and immune repertoire sequencing, as well as spatial transcriptomics. This census identified 121 cell types and states, defined developmental trajectories, and enabled an understanding of the functional units of the tonsil. Exemplarily, we stratified myeloid slan-like subtypes, established a BCL6 enhancer as locally active in follicle-associated T and B cells, and identified SIX5 as putative transcriptional regulator of plasma cell maturation. Analyses of a validation cohort confirmed the presence, annotation, and markers of tonsillar cell types and provided evidence of age-related compositional shifts. We demonstrate the value of this resource by annotating cells from B cell-derived mantle cell lymphomas, linking transcriptional heterogeneity to normal B cell differentiation states of the human tonsil.

Indexed as

B-LymphocytesPalatine TonsilAdultHumansadaptive immunityagingHuman Cell Atlashuman tonsilinnate immunitymantle cell lymphomasecondary lymphoid organssingle-cell genomicsspatial transcriptomics

Identifiers

PMID38301653
PMCPMC10869140
OpenAlexW4391406637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.